Our interpretation and recommendations on the recent regulatory guidance’s for Sponsors and CROs.
The statistical considerations for protocol amendments in the areas recommended by regulatory authorities using a case study.
Statistical considerations for ongoing clinical trials during COVID-19 crisis.
Categories: Events
From this webinar you will learn: Insights derived from www.clinicaltrials.gov data to showcase the impact of COVID-19 on ongoing clinical trials by phase, recruitment status, sponsors and therapeutic area.